Keros Therapeutics Inc

NASDAQ:KROS   10:56:15 AM EDT
50.43
-0.68 (-1.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Keros Therapeutics Inc Stock, NASDAQ:KROS

1050 Waltham Street, Suite 302, Lexington, Massachusetts 02421
United States of America
Phone: +1.617.314.6297
Number of Employees: 136

Description

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.